Proteins can transfer electrons at a distance Blog Post

Researchers from the Institute for Bioengineering of Catalonia (IBEC) al PCB have published a study in Nature Communications that reveals that electron transfer can take place while a protein is approaching its partner site, and not only when the proteins are engaged, as was previously thought. The results open up a new way of thinking about how proteins interact, and can have implications in a better understanding of many processes – such as photosynthesis, respiration and detoxification – in which electron transfer plays an important role.

 

Whole Genix wins the 2018 Mediterráneo Excellente Prize for Medical Innovation Blog Post

The company Whole Genix, headquartered in the Barcelona Science Park, received the 2018 Mediterráneo Excelente Prize in the Medical Innovation category. This award was received during the gala marking the IV edition of these prizes, held on Friday in Hotel Arts in Barcelona. With these awards, the editorial group El Suplemento aims to assess and highlight entrepreneurial, scientific and cultural talent, as well as social and charity initiatives undertaken by companies, institutions and professionals from the Mediterranean Arc.

 

Fundación GAEM launches its inclusive charity campaign ‘Yo Doy mis Pasos’ Blog Post

GAEM Foundation, headquartered in the Barcelona Science Park, launches its inclusive charity campaign Yo Doy mis Pasos’ [I give my steps], which aims to raise 1 million euros to promote biomedical research in multiple sclerosis, an incurable neurodegenerative disease which affects around 8,000 people in Catalonia and 50,000 in Spain. It is also the second biggest cause of disability in young people in developed countries after road accidents.

 

AELIX Therapeutics and Gilead Sciences enter into a clinical research collaboration agreement for HIV Cure Blog Post

AELIX Therapeutics, a clinical-stage biotechnology company based in the Barcelona Science Park and specialized in the discovery and development of immunotherapies for HIV infection, announces that it has entered into a clinical research collaboration with Gilead Sciences, a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Both companies will jointly evaluatejointly evaluate proprietary investigational products in a strategic clinical study aimed at achieving a functional cure of HIV infection.

 

IBEC and IRB Barcelona are awarded funding from the Spanish Association Against Cancer Blog Post

Yesterday, coinciding with World Cancer Research Day (WCRD), which takes place on 24 September each year, theSpanish Association Against Cancer (Asociación Española Contra el Cáncer, AECC) celebrated the 2018 AECC Cancer Research Grants awards ceremony. Among the proposals selected are two projects from the Institute for Bioengineering of Catalonia (IBEC) and five from the Institute for Research in Biomedicine (IRB Barcelona), which is based at PCB.

 

IRB Barcelona has been awarded two ERC Proof of Concept to tackle colon cancer and cardiotoxicity Blog Post

Eduard Batlle and Angel R. Nebreda, ICREA researchers at the Institute for Research in Biomedicine (IRB Barcelona), have been awarded an ERC Proof of Concept grant. Over the next 18 months and supported by 150,000 euros of funding each, they will devote their efforts to developing tools with potential therapeutic applications in the field of oncology. This is the second time that these scientists have received an ERC PoC grant.